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 i 
ABSTRACT 
Glioblastoma multiforme (GBM) is an aggressive Grade IV astrocytoma with a poor survival 
rate. This is largely due to the GBM tumor cells migrating away from the primary tumor site 
along white matter tracts and blood vessels leading to secondary tumor sites. It is unknown 
whether the microenvironment nanotopography influences the biomechanical properties 
of the tumor cells. Although these tumor cells have an innate propensity to migrate, we 
believe that the nanotopography changes the biomechanical properties to enhance the 
migratory phenotype.  To study this, we used an in vitro polycaprolactone aligned 
nanofiber film that mimics the nanotopography of the white matter tracts and blood 
vessels to investigate the mechanical properties of the GBM tumor cells. Our data 
demonstrate that the cytoskeletal stiffness, traction force, and focal adhesion area are 
inherently lower in invasive GBM tumor cells compared to healthy astrocytes. Moreover, 
the tumor cytoskeletal stiffness was significantly reduced when cultured on the aligned 
nanofiber films compared to smooth and randomly aligned nanofibers films. Analysis of 
gene expression also showed that tumor cells cultured on the aligned nanotopography 
upregulated key migratory genes and downregulated key proliferative genes. In addition, 
cell cycle analysis exhibited a reduced proliferative state on aligned nanofibers, 
highlighting the dichotomy between proliferation and migration observed in GBM. Finally, 
focal adhesions of tumor cells were larger and more elliptical when grown on the aligned 
fibers, suggesting a more migratory state. Therefore, our data demonstrate that the 
invasive potential is elevated when the tumor cells are cultured on an aligned 
nanotopography. This in vitro model can further be used to identify the GBM tumor cells’ 
response in a mimetic in vivo tumor microenvironment and elucidate how the aligned 
nanotopography transduces into altered gene and protein expression, thus providing a 
mechanism to target to inhibit the enhanced migratory behavior observed in these cells.  
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CHAPTER 1: INTRODUCTION 
Glioblastoma multiforme (GBM) is an aggressive malignant brain tumor that 
accounts for 45.6% of primary brain tumors [1]. Standard clinical treatments include 
surgical resection, chemotherapy, and radiation therapy. However, with a combination of 
these treatments, the average survival time is about 14.6 months [2]. Moreover, the 
recurrence rate remains high (~90%) due to the highly invasive nature of the GBM cells [3]. 
In addition, cancer initiating cells (CICs), a self-renewing subset of the heterogenic cell 
population, are highly migratory, invasive, and are responsible for recurrence of the tumor 
[4]. It has been shown that the GBM cells migrate and invade healthy brain tissue along 
white matter tracts and blood vessels [5, 6].  However, it has yet to be elucidated whether 
this biological phenomenon is due to the biochemical or biomechanical cues provided by 
these structures. It is critical to understand why these tumor cells migrate along these 
nanotopographical paths in order to develop therapies to inhibit the migration of these 
tumor cells from the primary tumor mass. 
Cellular biomechanics are responsible for a variety of biological functions in 
eukaryotic cells, including migration, differentiation, morphogenesis, and proliferation [7, 
8]. Specifically, these processes are largely dependent on the cytoskeleton structure and its 
response to the surrounding extracellular matrix (ECM). Cells adhere to the local 
substratum via integrins, which cluster together leading to the recruitment of proteins 
necessary for the formation of focal adhesions and stress fibers [9]. Topographic 
organization of the ECM plays a key role in directing cell behavior by providing three-
dimensional cues to the cell [10].   
The cytoskeleton and ECM are drastically altered in brain tumors. The actin 
filaments of cancer cells are transformed and their adhesion to the surrounding ECM is 
modified. Upon oncogenic transformation, the actin cytoskeleton is reorganized to allow 
for an elongated cell morphology aiding in directional migration [11]. Further, actin-rich 
membrane protrusions, including, including lamellipodia, filopodia, and invadopodia, are 
formed along the leading edge of the cell and release proteinases to degrade the 
surrounding ECM, further aiding in cell migration  [11-13]. Together, this affects the cells’ 
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deformation, altering their ability to stretch and contract. As these cells are more 
deformable, it is much easier for these cells to invade through tighter spaces compared to a 
healthy cell that is less deformable [12]. The cytoskeletal stiffness of cells has been shown 
to correlate with the migratory and invasive potential in a variety of cancer types, including 
ovarian, breast, prostate, and bladder, but has yet to be investigated in GBM [14-20].  
It is difficult to understand the invasive nature of these cells without a comparable 
in vitro model that is able to recapitulate the complex in vivo tumor microenvironment. 
While the ideal approach would be to use an in vivo tumor model, limitations with current 
technology do not allow for monitoring at the microscopic, single cell level. In addition, 
traditional in vitro models employed to quantify migration use rigid 2D substrates, which 
do not provide a true assessment of tumor invasion due to their lack of nanotopography 
and appropriate substrate stiffness. By developing an in vitro model that mimics the in vivo 
microenvironment, systematic studies may be completed to better evaluate the molecular 
mechanisms responsible for tumor cell migration, as well as the cellular responses to the 
nanotopographic cues. Jain et al. previously fabricated a thin film made of aligned 
electrospun polymeric nanofibers that mimicked the nanotopographical cues provided by 
the white matter tracts and blood vessels, and showed that intracortical tumor cells on the 
film were predominantly in a migratory state than proliferative state. Cells on the aligned 
fibers migrated much further than those on a substrate without topography [21]. In 
addition to modeling GBM migration, electrospun nanofibers have also been used as a 
model for breast cancer cell invasion [22] and embryonic myogenesis [23]. 
In this study, we investigated the mechanical differences between healthy cells and 
GBM tumor cells, as well as how the alignment and nanotopography of the nanofibers affect 
the tumor cell response in terms of their migration/invasion potential. As seen in other 
cancer types, the more invasive, malignant tumor cells were softer than less invasive tumor 
cells and their respective healthy, non-mutated cells [16, 18, 20, 24].  To our knowledge, 
investigating the invasive potential in relation to cytoskeletal stiffness for GBM tumor cells 
has not been previously reported.  In addition, by using an aligned nanofiber film to mimic 
the white matter tracts and blood vessels, we demonstrated that nanotopography affected 
cellular biomechanics. By examining the cytoskeletal stiffness, cytoskeletal organization, 
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and gene expression of GBM cells cultured on aligned nanofibers, randomly aligned 
nanofibers, smooth film, and tissue culture polystyrene (TCPS), we identified substrate 
nanotopography is correlative with the GBM tumor cells’ propensity to be in a more 
migratory or proliferative state.  
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CHAPTER 2: REVIEW OF LITERATURE 
2.1. GLIOBLASTOMA MULTIFORME 
Primary brain tumors are an abnormal mass of mutated cells that originate in the 
brain. Tumors that arise from glial or precursor cells are called gliomas, and account for 
about 80% of malignant primary brain and central nervous system (CNS) tumors. Gliomas 
are classified into four histological grades (I-IV, in increasing aggressiveness) based on 
their abnormality and growth rate. Glioblastoma multiforme (GBM, WHO grade IV) is a 
malignant brain cancer that is believed to arise from astrocytes. While it is rare, with an 
incidence rate of 3.19 per 100,000 person-years, it is the most common malignant primary 
CNS tumor, accounting for 45.6% of primary malignant brain tumors [1]. Current 
treatments include surgical resection, chemotherapy, and radiotherapy, however even with 
these treatments; average survival time is about 14.6 months [2]. Furthermore, even after 
the tumor is removed, recurrence is virtually inevitable (~90% recurrence rate) due to the 
extensive invasive nature of GBM cells [3].  
While it is uncommon for GBM cells to metastasize to other areas of the body, one of 
the hallmarks of this disease is that individual tumor cells have the ability to diffusely 
invade healthy brain tissue. This makes complete removal of the tumor difficult, despite 
multi-modal treatments. Tumor cells can cross hemisphere, and have been shown to 
migrate more than 4-7 cm from primary tumor sites, leading to secondary tumor sites [25]. 
As shown in Figure 1, the main means of migration is along white matter tracts and blood 
vessels of the brain, which act as ‘highways’ for cell migration [5, 6]. Cellular mechanisms 
responsible for the migratory nature of these cells remain a research focus.  
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Figure 1: GBM tumor cells migrating along blood vessels and white matter tracts. A) Histologic section of GBM cells surrounding 
vessels (arrow) [6]. B) Histologic section of corpus callosum, myelinated axons stained blue. Arrow indicates migrating cell [5].  
The cancer initiating cells (CICs, also called cancer stem cells), a subset of the 
heterogenic cell population, are highly migratory, invasive, resistant to therapy, and 
responsible for the recurrence of the tumor [4]. These cells are characterized as their 
ability to self-renew, aberrantly differentiate, initiate tumorigenesis, and migrate [26]. 
While established human glioblastoma cell lines, such as U87MG and A172, have been used 
to model GBM and in drug treatment assays, the phenotypic characteristics and genetic 
modifications bear little similarity to cells isolated from the heterogenic primary brain 
tumor. Therefore, the use of GBM models based on CICs, specifically primary CICs, is more 
biologically relevant and has implications for the better understanding of tumor biology 
and development of new therapies [27].  
2.2. CELLULAR BIOMECHANICS/CYTOSKELETAL DYNAMICS AND BIOMECHANICS 
Cell mechanics are responsible for a variety of biological functions in eukaryotic 
cells, including migration, differentiation, mechanotransduction, morphogenesis, and 
proliferation [7, 8]. Specifically, these processes are largely dependent on the cytoskeleton 
and its interactions with the surrounding ECM. The cytoskeleton is the cell’s internal 
scaffolding, which is comprised of an interconnected network of biopolymers and proteins.  
Collectively, the cytoskeleton organizes contents of the cell, connects cell both with the 
surrounding ECM, and aids in generating force that facilitates cell motility [28]. The 
architecture and organization of the different cytoskeleton components alter the shape and 
mechanical response within the cell, which in turn, affects the cell-cell and cell-matrix 
interactions. These changes can alter the mechanical properties in cells, and can lead to 
disease development [9, 28]. 
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The cytoskeleton of eukaryotic cells contains three distinct polymeric structures: 
actin microfilaments, intermediate filaments, and microtubules. Actin exists as a free 
monomer G-actin (globular) or as a linear polymer F-actin (filamentous), both of which are 
important for cell motility and contraction. F-actin can further be organized into stress 
fibers, or closely packed arrays of filaments, and are formed when the cell needs additional 
strength, such as during migration. F-actin filaments also concentrate around focal 
adhesion sites. Similar to actin, intermediate filaments aid in the maintenance of cell shape 
and provide structural integrity for the cell. Named intermediate due to their approximate 
diameter of 10 nm, their size is in-between the diameter of actin microfilaments (7 nm) and 
microtubules (25 nm). Finally, microtubules consist of alpha-tubulin and beta-tubulin, 
which dimerize to form a long, hollow, tubular structure. Microtubules aid in dictating cell 
shape, and play a role in cell migration and mitosis [29, 30].   
 Cells are able to sense their external environment and create signals through 
adhesions onto the substratum Adhesions of the cells to the ECM are predominantly 
modulated via integrins. Integrins are transmembrane receptors that give cells a 
connection to the ECM, and communicate signals from the cell to the surrounding space.  In 
cell invasion, integrins recruit proteases to the leading edge of the cell, which aid in 
breaking down the surrounding matrix [31]. When cells attach to the ECM, integrins cluster 
on the cytoplasmic portion of the cell surface, and are bound together by crosslinkers that 
bind the cytoplasmic tails of the integrins together [32]. Clustering leads to the recruitment 
of adaptor/scaffold and signaling proteins, including talin and vinculin, that form focal 
adhesions, which link the actin cytoskeleton firmly to the ECM. Talin initiates focal 
adhesion assembly by linking the cytoplasmic portions of the integrins to either actin 
binding proteins α-actinin and/or vinculin [9].  
Focal adhesion presence plays a role in cell morphology, as formation of focal 
adhesions leads to cells with spread morphology. Without focal adhesions, there is reduced 
substrate adhesion, and an increased population of non-adherent cells.  Focal adhesion 
formation also plays a role in cell motility, as when focal adhesions grasp the surrounding 
ECM along the leading edge. The traction forces within the cell are generated, which are 
necessary to move the cell forward. In order for the cells to migrate, however, the cells 
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must also release from the ECM. By synchronizing a formation and turnover of focal 
adhesion attachment at the leading edge and trailing edge, respectively, cells will migrate 
forward (Figure 2). Thus the generation and turnover of focal adhesions along the leading 
and trailing edge, respectively, is vital for the continuous directional migration of cells [9].  
 
Figure 2: Focal adhesion formation during cellular migration. An imbalance of formation and turnover of focal adhesions within the 
cell to the ECM leads to either a stable adhesion (i) or unstable adhesion (ii). Rapid formation and turnover at the leading edge of the cell, 
along with turnover of focal adhesions at the trailing edge, leads to promoted migration (iii) [9].  
Different processes regulate the assembly/disassembly of focal adhesions. For 
example, Rho/ROCK is one pathway that regulates the clustering of integrins on the cell 
surface. When microtubules extend to the focal adhesions, the integrins disassemble and 
internalize from the surface [9]. In addition, adaptor protein, paxillin, binds to vinculin, and 
provides a platform for protein tyrosine kinases, such as focal adhesion kinase (FAK) [33]. 
FAK is responsible in the turnover of focal adhesions, which is necessary to allow cell 
migration. Overexpression of FAK has been correlated with enhanced migration and 
increased invasive potential in human tumors [34, 35].  
Substrate and ECM nanotopography also have an effect on stress fiber and focal 
adhesion formation. Human mesenchymal stem cells cultured on 350 nm gratings of TCPS 
exhibited increased expression of integrin subunits compared to unpatterned controls. In 
addition, the cells on the nanotopographic substrates exhibited an elongated morphology 
with an aligned actin cytoskeleton and a dense focal adhesion population around the poles 
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of the cells, compared to a random dense network on the unpatterned control [10]. Similar 
results were found across a variety of cell types including epithelial, kidney, and fibroblast 
cells [36-38].  
 CELL MECHANICS AND DISEASE 
Cellular behavior, as well as the cytoskeleton, is altered in a disease state.  Due to 
technical advancements, cellular mechanics has been a research focus to identify 
relationships between cell structure, biomechanics, and disease states [12]. Cells are 
dynamic and are continuously changing and responding to their chemical and mechanical 
environment. In order to identify a relationship between the chemobiomechanical pathway 
and disease, systematic studies must be completed under conditions that mimic the in vivo 
microenvironment. The lack of a comparable model limits the amount of comprehensive 
studies completed.  
 The cytoskeleton and ECM are drastically altered in cancer. The actin filaments of 
cancer cells are transformed, ultimately affecting their deformation. This transformation 
alters cellular ability to stretch and contract, which allows cells to migrate through tissues 
much faster and easier than normal cells, leading to tumor metastasis [12].  
 MECHANICS AND BIOLOGY OF GLIOBLASTOMA 
Cellular migration is an important process that is facilitated by several mechanical 
processes including adhesion and force generation within the cell. Thus, it is important to 
understand the molecular mechanisms behind the migration of glioblastoma cells in order 
to develop therapies to inhibit the outward growth of cells from the primary tumor mass. It 
has been previously determined that glioblastoma cells preferentially invade along the 
blood vessels and white matter tracts in the brain. Unlike in other cancer types, GBM 
tumors do not invade into blood vessels, and rarely metastasize to other organs. This is 
believed to be due to the specialized brain ECM compared to other organs. In addition to 
being softer than other tissue, brain ECM has a low percentage of fibrous proteins such as 
collagen and laminin, and is instead largely comprised of hyaluronic acid (HA), a non-
sulfated glycosaminoglycan. HA is believed to play an important role in GBM progression, 
as malignant gliomas have exhibited greater concentrations of HA than normal brains [39]. 
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Cell invasion is dependent on tumor cell attachment to the ECM via cell surface 
markers and integrins.   The signal transduction from HA causing the cells to migrate is 
partly due to the cell-surface receptor CD44, which is correlated with malignancy in 
gliomas. CD44 activation promotes downstream signaling of Rho family GTPases, 
ultimately leading to migration.  Degradation of ECM by hydrolytic enzymes secreted by the 
tumor cells creates the intracellular space for tumor cells to migrate into. The actin 
cytoskeleton rearranges and is extended into the newly remodeled ECM, leading to focal 
adhesion formation at the leading edge, generating the traction necessary to move the cell 
forward [40].  
There are many molecular pathways that have been implicated in glioblastoma 
migration, including the Notch pathway. This pathway is important for embryonic 
development, however, has also been implicated in cancer progression. Notch exists as 4 
highly homologous large transmembrane receptors (1-4) consisting of an extracellular, 
transmembrane, and an intracellular domain (NICD). When either of the Notch receptors is 
activated, NICD is cleaved and released from the membrane, which translocates to the 
nucleus leading to transcription of downstream target genes [41].  
Notch deregulation is also believed to play a role in epithelial-mesenchymal 
transition (EMT), which plays a role in tumor aggressiveness and progression. EMT is a 
process in which epithelial cells undergo morphological changes characterized from the 
epithelial phenotype, with high expression of E-cadherin, actin cytoskeleton organization, 
and tight cell-cell contacts, to the elongated mesenchymal phenotype, with increased N-
cadherin expression and cell-matrix interactions. Similar to the Notch pathway, EMT is 
linked with embryogenesis as well as tumor progression and metastasis. Specifically, 
translocation of E-cadherin from the cell membrane to the nucleus leads to induction of 
EMT. Repression of E-cadherin via the transcription factors SNAI1, TWIST, and ZEB1 aid in 
driving cancer development [42]. Notch has been shown to promote EMT through the 
regulation of SNAI1. Zhang et al. showed that elevation of Notch1 signaling in GBM cells 
and in tumor biopsies led to increased tumor metastasis and EMT markers [41].  The 
authors proposed that Notch signaling resulted in AKT activation, which in turn resulted in 
increased NF-κB and β-catenin signaling. Together, this increased signaling resulted in the 
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promotion of cell migration and invasion by the upregulation of EMT markers SNAI1, ZEB1, 
and vimentin [41]. Notch is believed to affect SNAI1 through by recruiting the NICD to the 
Snai1 promoter [43].   
As discussed earlier, in order for cells to invade surrounding tissue, they must 
degrade the surrounding matrix. The proteolytic enzymes responsible for this degradation 
include matrix metalloproteinase-2 (MMP-2) and MMP-9, which have been closely 
correlated with glioblastoma invasiveness [44, 45]. The metastasis suppressor gene 
reversion-inducing-cysteine-rich protein with kazal motifs (RECK) negatively regulates 
MMP-2 and MMP-9 by directly inhibiting membrane protease activity, influencing their 
release from the cells, and sequestering of MMPs at the cell membrane [46]. 
Downregulation of RECK is essential for the invasiveness of GBM cells [47].  Silveira Corrêa 
et al. has shown the effect of RECK expression on the cytoskeleton of the T98G glioblastoma 
cells. Cells transfected to overexpress RECK were closely packed together and exhibited 
few lamellipodia and greater amounts of stress fibers, indicating decreased cell motility. 
The control cells however were more polarized in the direction of migration, and had the 
presence of lamellipodia and stress fiber formation [48].  
 Cyclin dependent kinases (CDKs) and cyclins are a research focus for GBMs as 
regulators of cell cycle progression. CDK20 (also called cell cycle-related kinase) is a CDK-
activating kinase that is important for the cell cycle [49]. Elevated levels of CDK20 have 
been reported to be essential for proliferation in a variety of cancer cell lines, and is 
believed to play an oncogenic role in GBM. CDK20 suppression arrests cells at the G0-G1 
phase by decreasing CDK2 phosphorylation, and also knockdowns expression of cyclins in 
human cancers, including glioblastoma [49-51]. Specifically, CDK20 expression is 
correlated with cyclin D1 expression, which is required for progression through the G1 
phase [49, 52].  
 In addition, there is an observed dichotomy between proliferation and migration in 
GBMs, also known as the “go-or-grow” phenomenon. With GBM cells grown in vitro, the 
invasive tumor cells along the leading edge exhibited a decreased proliferation rate 
compared with the tumor core. Similarly, when cells were grown on a permissive ECM that 
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supported migration, cells exhibited a more migratory phenotype instead of a proliferative 
one, compared to the non-permissive substrate which exhibited the opposite [53]. Similarly, 
soluble mitogens, such as transforming growth factor beta 1 (TGF-β1), have been shown to 
stimulate tumor invasion and suppress proliferation in vitro [54]. Cells transfected to 
express receptor tyrosine kinase EphB2 to promote migration exhibited a reduced cyclin B 
and cyclin D1 expression, indicating reduced proliferation [55]. Furthermore, with cells 
that were selected for an enhanced migratory phenotype, the growth rate was slightly 
impeded compared with the normal cell population [56]. 
 Similar results have also been observed in vivo. Using stereotactic glioma biopsies, 
invasive cells in the white matter and cortex exhibited a decreased proliferative index. 
Similar results were also observed with invading cells that were far from the tumor core 
[57]. Using an implantable nanofiber film to direct tumor cell migration, Jain et al. showed 
that cells were in a less proliferative state on the aligned fibers compared to a smooth film 
control, as indicated by a reduced Ki-67+ staining. As shown in Figure 3, F-actin staining 
analysis showed that cells grown on the aligned film exhibited fibrous F-actin staining 
versus more punctate F-actin on smooth film, suggesting a more suspended state on the 
smooth film [21].  
 
Figure 3: GBM cells on aligned fibers exhibit migratory phenotype. Actin (red) of cells on smooth film exhibited punctate filaments 
indicating a suspended, less migratory state. Uniform actin filaments were exhibited on tumor cells on aligned nanofiber film. Scale bar = 
400 μm [21]. 
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2.3. ASSESSING THE MECHANICAL PROPERTIES OF CELLS 
As mentioned earlier, cellular mechanics are currently being researched to identify 
biophysical markers for diseases. Cytoskeletal stiffness and traction forces are two 
biophysical properties that have been investigated in other cancers, but have yet to be fully 
investigated in glioblastoma. These two properties can be assessed via atomic force 
microscopy (AFM) and traction force microscopy (TFM), respectively.  
2.3.1. CYTOSKELETAL STIFFNESS 
Cells are considered a viscoelastic material as they display both elastic and time-
dependent responses to deformation [58]. Recently, there has been increasing evidence 
that mechanical changes, specifically the cytoskeletal stiffness, at the single cell level are 
correlative with human disease, including cancer. Several biophysical adaptations are often 
associated with cancer cells as they become more invasive or metastatic. As previously 
mentioned, these cells often express fewer adhesion receptors, leading to more rounded 
cell morphology as well as a loss of cytoskeletal tension. Cell tension in healthy cells is a 
factor in cytoskeletal properties including stability, remodeling, stiffness, and traction, the 
latter two being important in this study [59]. Thus, researchers have been studying how 
cancer progression may be linked with cytoskeletal mechanics.  
Several methods have been developed to determine cell stiffness, including using 
optical tweezers or an atomic force microscope (AFM) [58]. AFM is a surface 
characterization technique that has also been adopted for imaging and characterization of 
biological samples due to its high sensitivity and spatial resolution. In its simplest form, the 
AFM consists of microscopic-sized tip connected to a cantilever beam, which is used to 
indent/interact with the sample. The tip of the cantilever can come in a variety of shapes 
and sizes depending on its application. As shown in Figure 4, the tip is the part of the probe 
that comes in contact with the cell, while the cantilever itself acts as a spring to measure 
the contact force. A piezoelectric actuator is used to move the AFM probe in the Z-direction 
toward or away from the material. The shape and material of the cantilever probe are used 
to calculate its spring constant, and together with laser tracking of the cantilever deflection 
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to a photodetector, contact force can be calculated. Cell elasticity can then be calculated by 
calculating the force versus indentation data [58-61].  
 
Figure 4: Outline of how cell stiffness measurements are performed on living cells using AFM. From right to left, as the AFM tip 
approaches the cell and makes contact with it, the cantilever bends, altering the laser beam deflection angle. A stiffer cell will result in a 
steeper deflection curve than a soft cell [62].  
AFM is a useful tool for probing cellular mechanics. By using this technique, it has 
been reported that actin filaments are highly important in the mechanical stability of living 
cells, while microtubules do not have any effect on elasticity [63]. In addition, it has also 
been reported that the actin cytoskeleton/organization plays a role in human mesenchymal 
cell mechanical properties during differentiation [64]. In 2003, a link between AFM 
mechanical measurements and detection of disease was first suggested [61]. Moving 
forward, it was then shown that the cytoskeletal stiffness of breast [16], ovarian [18], 
prostate [24], lung, and pancreatic cancer cells [20] were intrinsically softer than their 
normal/healthy counterparts. In an ovarian cancer study, highly invasive cancer cells were 
less stiff than their less invasive parental cells, further suggesting the cytoskeletal stiffness 
can be used as a biomarker for invasive potential [18]. To our knowledge, a comparative 
study of the cytoskeletal stiffness of non-malignant astrocytes, GBM cell lines, and primary 
GBM CICs has yet to be reported.   
2.3.2. CELL TRACTION FORCES 
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When cells attach to a substrate, they spread and generate intracellular traction 
forces through ATP-fueled actomyosin interactions [65]. Cell traction forces play a role in 
migration, as these forces need to be generated and exerted to the ECM or substratum to 
move the cell forward. In addition, during cell migration, actin polymerization and focal 
adhesion assembly at the leading edge of the cell also produces traction forces. The 
turnover of focal adhesions at the leading and trailing edge aid in the directional cell 
migration [65, 66]. 
Traction force microscopy (TFM) is a technique used to quantify cellular traction 
forces and stresses. While a variety of TFM techniques exist, the basic principle is to 
determine the displacement of the stressed ECM or substratum at the surface of the cell to 
create a stress vector. The strain and elastic modulus of the substrate can then used to 
calculate the traction forces. While some methods involve culturing cells on pillars [67] or 
within 3D hydrogels [68], in this study, cells were grown on a flexible polyacrylamide gel 
with fluorescent microbeads to aid in determining substrate displacement.  
It has been shown previously that metastatic breast, prostate, and cancer cell lines 
exert more traction forces than their non-metastatic counterparts [69]. Conversely, an in-
depth study of comparing the traction forces in breast cancer cells with varying degrees of 
metastatic potential showed that the more invasive cells produced less traction force than 
the control cells and less invasive counterparts [70]. Thus, as the relationship between 
traction force and invasiveness varies between different types of tumors, more 
investigation of traction forces and cancer cell migration in GBM needs to be completed to 
help explain this phenomenon.  
2.4. IN VITRO MODELS 
2.4.1. TRADITIONAL MODELS 
In order to identify the relationship between the biomechanical pathway of cells and 
disease, systematic studies must be completed under conditions that best mimic the in vivo 
microenvironment. The easiest, and most commonly used, model to quantify migration is 
the scratch test/wound-healing assay. With this test, cells are grown as a monolayer on 
tissue culture plastic, and a ‘scratch’ is made using a pipette tip to mimic a wound. Cells 
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migrate into this space and close the wound, which is then used to determine the migration 
rate of the cells. While this test is easy to conduct and requires minimal resources, the lack 
of topography and the use of a rigid plastic substrate that is not comparable to a living 
tissue does not provide a true assessment of cell migration or invasion.  
Second, polyacrylamide gels have also been researched as a model. The mechanical 
properties of the gels are highly tunable and can highly resemble the stiffness of the brain 
ECM. Groups have also been used three-dimensional hyaluronic acid gels to better 
resemble the brain ECM composition and model cell infiltrative behavior [39]. While these 
gels can mimic the stiffness and matrix of the tumor environment, they do not mimic the 
topography that these tumor cells migrate along, and thus do not meet the needs of this 
study. 
Organotypic brain slices have also been used to quantify cell migration. Brains are 
isolated from an animal model, and cut into 300 µm thick slices. Cells are then seeded in the 
area of choice on the slice, and outgrowth and migration from the region is measured [71]. 
While this model has the benefit of having a similar ECM and nanotopography of the native 
brain, the high cost of animal studies and large sample-to-sample variation between brains 
make them difficult to work with. In addition, the lack of stability in the slices hinders them 
from being used for long-term studies.  
Thus, in vitro assays that more closely mimic the in vivo microenvironment need to 
be developed as they can better assess and characterize cancer cell migration and its 
abnormal proliferative capabilities, leading to the development of anti-invasive drugs, 
ultimately providing patients with better and more effective therapies.  
2.4.2. ELECTROSPINNING 
In order to create a scaffold that mimics the nanotopography of the white matter 
tracts and blood vessels, a nanotopgraphic film with submicron diameters needs to be 
developed. Fortunately, electrospinning is a process that can be used to meet this need. 
Originally discovered in 1934 when an electric field was used to produce polymer threads, 
electrospinning is a material fabrication technique that creates long, continuous nanofibers 
through an electrically charged jet of polymer solution. In its basic form, a polymer solution 
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is infused through a syringe and is charged with a high voltage (Figure 5). A droplet from 
the charged polymer is elongated into a conical shape (Taylor cone), and a thin fiber is 
ejected from the droplet, which accumulates onto a grounded collector [72, 73]. 
 
Figure 5:  Schematic of electrospinning apparatus. Using a rotating mandrel as a grounded collector, aligned nanofibers will be 
generated.  
The process is highly tunable, as the controllable parameters such as electric field 
between the nozzle and collector, flow rate, deposition distance, and polymer 
concentration all play a factor in the fiber properties. For example, the deposition distance 
affects how much solvent is evaporated, thus the greater the distance, the thinner the fibers.  
In addition, the orientation of the fibers can change based on the collector. When fibers 
accumulate on a static collector, randomly oriented nanofibers are created. However, when 
a rapidly rotating mandrel is used, highly aligned nanofibers can be generated [73].  
Electrospinning can be used in a variety of applications in the biomedical field, 
including drug release, wound dressing, and tissue engineering. Due to its highly tunable 
properties and nano-scale, electrospun nanofibers can mimic the properties of the ECM to 
allow researchers to examine cell behavior in vitro in a physiologically relevant 
environment [73]. Electrospun nanofibers have been used to investigate the relationship 
with topography on the osteogenic differentiation of bone marrow stromal cells [74], 
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neurite outgrowth from dorsal root ganglia [75], and myogenic differentiation from 
embryonic stem cells [23].  
More important for matters of this study, electrospun nanofibers have been 
investigated as mimetic model for cancer cell invasion, specifically in breast cancer and 
GBM. The nanofibers mimic the tumor-associated collagen signatures associated with 
metastatic breast cancer [50]. In addition, Jain et al. previously demonstrated that an 
aligned nanofiber model closely resembles the nanotopography of the white matter tracts 
and blood vessels that the tumor cells migrate along in GBM [21]. Aligned nanofibers have 
been shown to lead to significant increases in migratory related genes and proteins [76, 77]. 
In addition, GBM tumor cells on aligned nanofibers were significantly faster and migrated 
further than when cultured on random nanofibers [76, 78]. Specifically, Johnson et al. 
found that effective velocities of GBM cells on the aligned fibers were 4.2 ± 0.39 µm/hr on 
aligned nanofibers, compared to 0.8 ± 0.08 µm/hr on the randomly oriented nanofibers 
[77]. Jain et al. also observed similar trend in GBM cell speed, with cells on aligned fibers 
migrating up to 3-fold faster than those migrating on a smooth film control [21].  By using 
this nanofiber model to mimic GBM cell migration, relationships between the 
biomechanical pathway and this disease can be systematically investigated and elucidate 
the enhanced migratory mechanism involved in this disease. 
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CHAPTER 3: HYPOTHESIS AND SPECIFIC AIMS 
 As it is difficult to understand the mechanism of GBM migration using an in vivo 
model due to limitations with current technology, in vitro models that closely mimic the 
tumor microenvironment are increasingly alluring. By using smooth film, random 
nanofibers, and aligned nanofibers that mimic the nanotopography, specifically the 
alignment and nanofiber diameter, of the tumor microenvironment, systematic studies can 
be completed that can quickly identify the changes in GBM cellular mechanics. As it has 
been shown in other cancers that cell stiffness is correlative with more migratory cells, and 
that an aligned nanotopography promotes more motile GBM cells, we hypothesized that 
aligned nanofibers induce mechanical changes within GBM cells (i.e. cytoskeletal stiffness) 
that enhance a migratory state. 
Specific Aim 1 – Determine baseline mechanical properties (i.e. cytoskeletal 
stiffness, traction force) of glioblastoma multiforme cells and identify if 
differences correlate with degree of malignancy. 
We hypothesized that the more malignant cells will have stiffness due to their 
higher invasive potential. When a normal cell mutates and becomes tumorigenic, it 
develops invasive properties, which incorporate biomechanical changes. Rat pup 
astrocytes, human glioblastoma (GBM) cell lines, and primary human glioblastoma 
CICs were used to study the cell cytoskeleton and its properties using atomic force 
microscopy, traction force microscopy, immunocytochemistry for cytoskeleton 
staining.  
Specific Aim 2 – Determine whether aligned nanotopography substrates 
enhance the migratory state in GBM cells. 
We hypothesized that an aligned nanotopography substrate will promote a 
migratory cell state, as the aligned nanofibers mimic the paths tumor cells migrate 
in vivo. Nanotopographic substrates, aligned and randomly aligned nanofibers, and 
lack of nanotopography substrates, smooth film and tissue culture polystyrene, 
were used. Tumor cells were cultured on the different substrates, and cytoskeletal 
stiffness measurements were collected using AFM. Gene expression and cell cycle 
population were quantified using qRT-PCR and FACS to assess a relationship 
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between nanotopography and cell state. Further, vinculin and actin staining were 
used to identify cytoskeletal organization and assess a relationship between focal 
adhesions and an enhanced migratory state.  
3 .    
4 .   
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CHAPTER 4: MATERIALS AND METHODS 
4.1. CELL CULTURE 
Human glioblastoma multiforme tumor cell lines, U87MG and A172 (ATCC, 
Manassas, VA), were maintained and cultured in DMEM (Corning, Corning, NY), 
supplemented with 10% fetal bovine serum (FBS, Gemini Bio-Products, West Sacramento, 
CA), 1% penicillin-streptomycin, 1% L-glutamine, and 1% non-essential amino acids 
(Corning). U87MG cells expressing enhanced green fluorescent protein (eGFP) were 
generously donated by Dr. Ravi Bellamkonda (Georgia Institute of Technology). A172 cells 
were transfected using GFP-Actin fusion lentiviral particles (GenTarget Inc., San Diego, CA) 
and positive colonies were selected for expansion. Primary CICs, BT145 were generously 
gifted by Dr. Rosalind Segal (Dana-Farber Cancer Institute). The GBM CICs were cultured in 
DMEM/F12 (Corning), supplemented with B27 (Gibco, Life Technologies Grand Island, NY), 
15 mM HEPES (Alfa Aesar, Ward Hill, MA), 20 ng/mL EGF (Invitrogen, Carlsbad, CA), and 
20 ng/mL FGF (Invitrogen). Differentiated BT145 tumor cells were grown in DMEM 
supplemented with 10% FBS.  Primary rat astrocytes were isolated from Neonatal Sprague-
Dawley pups (post-natal day 2) and maintained in Neurobasal Medium (Gibco), 
supplemented with 10% FBS and 1X GlutaMAX (Gibco). 
4.2. PREPARATION OF NANOTOPOGRAPHIC SCAFFOLDS 
Aligned and randomly aligned nanofibers were fabricated using electrospinning as 
previously described [79]. Electrospinning was used to generate nanofiber films. Briefly, a 
10% polycaprolactone (PCL, Sigma, St. Louis, MO) was made by dissolving PCL in 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, Sigma) overnight. Approximately 0.5 mL of 
polymer was loaded into a 5-mL plastic syringe fitted with a 19 gauge blunt tipped needle 
and placed 10 cm from the collector, an aluminum foil coated mandrel (2”D x 4”L). A 
positive voltage was applied to the polymer by connecting a lead from a high power voltage 
source to the syringe needle. To fabricate aligned nanofibers with a diameter of 600-800 
nm, the syringe pump was set to flow rate 0.15 mL/hr, and charged with 5-8 kV (Figure 6). 
Fibers were collected for 20 minutes onto the mandrel spinning at 3000 RPM. To fabricate 
randomly oriented fibers, the flow rate was adjusted to 0.5 mL/hr, charged with 8 kV, and 
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collected for 10 minutes onto the mandrel spinning with at 15 RPM. To fabricate smooth 
film, 12% PCL was pipetted and spread onto a glass coverslip and the HFIP was evaporated 
under vacuum. Smooth film and TCPS were used as non-topographic controls. 
   
Figure 6: Electrospinning apparatus used in the Jain laboratory. Apparatus was maintained in a plastic enclosure for safety as well 
as to minimize any environmental factors. White box highlights tip of syringe (middle panel). When sufficient voltage is applied, droplet 
is elongated and Taylor cone is formed. After fiber spinning is complete, they are isolated and placed into tissue culture dishes where 
they are prepared for culturing (right panel).  
Following preparation, substrates were dried overnight to allow for residual solvent 
to evaporate. Samples were cut to fit into 60 mm dishes, and submerged in 100% ethanol, 
and removed from the glass/foil. After the ethanol evaporated, substrates were secured to 
petri dishes using UV glue. Prior to use, substrates were sterilized under a UV lamp for 30 
minutes, and coated with PureCol® Bovine Collagen (100 µg/mL, Advanced BioMatrix, San 
Diego, CA) for 1-2 hours at and allowed to incubate at 37C to facilitate cell attachment. The 
substrates were then washed 3 times with sterile phosphate buffered saline (PBS) prior to 
seeding the cells. 
4.3. CHARACTERIZATION OF SUBSTRATES 
To characterize the substrates, SEM was performed on the aligned nanofibers, 
randomly aligned nanofibers, and smooth film substrates as previously described [21].  
Briefly, samples were mounted onto stubs using carbon tape. Smooth film SEM images 
were taken using a FEI-TeneoLoVac SEM and aligned and randomly aligned nanofiber films 
were taken using a JSM-7000F SEM. Fiber diameter and degree of alignment analysis was 
completed using ImageJ.  
z 
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4.4. CYTOSKELETAL STIFFNESS MEASUREMENTS 
To measure the cytoskeletal stiffness measurements, tumor cells were seeded on 
the collagen-coated tissue culture polystyrene (TCPS) or PCL substrates at a density of 
20,000 cells per sample (Figure 7). The tumor cells were cultured for 24 hrs prior to testing. 
An MPF3D-Bio AFM (Asylum Research, Santa Barbara, CA) was used to measure the 
stiffness of cells as previous described [80]. Briefly, the DNP-D cantilevers were calibrated 
using the thermal method prior to experiment.  A Nikon Ti-S microscope (MVI, Avon, MA), 
was used to observe and select the desired cells for measurement. The AFM cantilever was 
placed over the perinuclear region of the cell, and an indentation was performed with a 
maximum cantilever deflection of 10 nm. After maximum deflection, the z-position of the 
AFM scanner was oscillated with a frequency of 10 Hz, amplitude of 25 nm, and duration of 
1.5 seconds. The AFM tip was removed from the cell, and the z-position of the tip and 
cantilever deflection was recorded. A total of 3 measurements were obtained at different 
locations in the perinuclear region of the cell, a minimum of 15 cells was measured for each 
sample, and each sample was tested in biological triplicates. The Hertz indentation model 
was used to calculate the stiffness of each cell using a custom MATLAB (MathWorks, Natick, 
MA) code.  
 
Figure 7: Schematic of how AFM was conducted on tumor cells on nanofiber substrates.  
4.5. CELL TRACTION FORCES 
Traction force measurements were determined by culturing cancer cells on 
polyacrylamide gels with a thin layer of fluorescent beads embedded within them. Briefly, 
2% 0.2-micrometer diameter FluoSpheres (Life Technologies) were diluted 1:200 in 
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ethanol, and 50 µl was pipetted onto clean, plasma treated 25x25 mm glass slides and 
placed in a 150 oC oven to facilitate an even distribution of spheres across the glass. Next, 
polyacrylamide solutions of 5% or 8% acrylamide and 0.08% or 0.1% bis-acrylamide, 
respectively, were made. Following, 64 µl of gel were pipetted onto 25x25 mm 
glutaraldehyde treated glass slides, and the glass slide with beads was gently placed on top, 
with the bead-coated slide of glass being in contact with the gel. After 7 minutes, the slides 
were separated using a razor blade. Slides were subsequently glued into customized petri 
dishes using UV glue, and hydrated using HEPES buffer until ready for use.  
Prior to plating, the gel was treated with sulfo-SANPAH (Pierce) and coated with 
PureCol® Bovine Collagen (100 µg/mL, Advanced BioMatrix, San Diego, CA). For sulfo-
SANPAH linkage, 500 µL of HEPES, 4 µL DMSO, and 0.5 g of sulfo-SANPAH were mixed and 
250 µL was pipetted onto each gel. Gels were placed under UV for 10 minutes to activate 
the crosslinker to bind to the gel. Gels were then rinsed with HEPES and coated with 
collagen, and incubated at 4oC overnight. After coating, collagen was removed, and rinsed 3 
times with HEPES. Once completed, 10,000 cells were plated onto the gels. After 24 hours, 
fluorescent images of the spheres and brightfield images of cell on the stressed gel were 
taken using an Olympus IX83 microscope.  Healthy cells, isolated from other cells were 
chosen, as it minimized any confounding effects from other cells exerting forces on the gels. 
Following initial imaging, media was removed, the plate was washed once with PBS, and 
0.25% trypsin EDTA (Corning) was added to release the cell from the substrate. After five 
minutes, cells detached from the substrate, and the gel returned to a relaxed state. 
Corresponding images of the beads were taken at the same location. Traction forces were 
calculated using MATLAB and ANSYS software (ANSYS Inc., Canonsburg, PA). A minimum 
of 7 cells were analyzed for each gel, and three gels were analyzed for each cell type.   
4.6. CYTOSKELETAL STAINING AND ANALYSIS 
Approximately 15,000 tumor cells or astrocytes were cultured on collagen-coated 
substrates overnight (about 24 hours) before being briefly rinsed with cytoskeleton buffer. 
Following this, cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized 
with 0.1% Triton-X-100 (Sigma) for 20 minutes, and blocked in 4% goat serum for 30 
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minutes. Cells were then incubated at 4 oC overnight with primary antibody for focal 
adhesion protein vinculin (1:500 in 4% goat serum in PBS, Sigma), then rinsed three times 
with PBS. Secondary antibody, Alexa-Fluor 594 goat anti-mouse (1:220, Invitrogen) in 2% 
goat serum in PBS, was used and incubated at room temperature for two hours. Slides were 
rinsed again with PBS, and F-actin was stained using phalloidin (Life Technologies) for 30 
minutes. Slides were rinsed again in PBS and counterstained with Hoechst 33342 (1:5000, 
Life Technologies) for 10 minutes. Coverslips were rinsed again, and glass slides were 
mounted using Fluoromount-G. A Leica SP5 Point Scanning Confocal microscope was used 
to visualize the cytoskeletal organization on the substrates. Due to the nanotopography on 
the nanofibers, Z-plane stacks and standard deviation z-projection were used to produce 
images on nanotopographic substrates.  
ImageJ (NIH, Bethesda, MD) was used to analyze the amount of positive vinculin 
staining when cultured on glass. Quantification of the focal adhesions from the collected 
images was completed using a modified protocol by Hozrum, et al. [81]. Briefly, vinculin-
channel images were imported into ImageJ, and the Subtract Background filter with a 
sliding paraboloid option with rolling ball radius of 50 pixels option selected. Next, local co-
ntrast was enhanced using the CLAHE plugin, with parameters block size 19, histogram 
bins 256, maximum slope 6, no mask, and fast option selected. Next, mathematical 
exponential filter was applied to minimize background. Next, the brightness and contrast 
and threshold were automatically adjusted. Finally, the Analyze Particles command was 
executed and the amount of total positive staining was recorded, including staining 
localized in the interior region of the cell as well as the periphery of the cell. Next the total 
vinculin area was divided by the projected cell area. A minimum of 15 cells was imaged per 
substrate, and each substrate was imaged in triplicate. 
In addition, morphometric analysis of the area, length, and shape factor 
(4π(area)/(perimeter)2) of the focal adhesions of the cells were conducted on the collected 
images using ImageJ software. A minimum of 7 cells was analyzed for each substrate, and 3 
substrates were analyzed for each condition. An average of each shape descriptor was 
calculated for each cell. 
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4.7. ANALYSIS OF KEY MIGRATORY AND PROLIFERATIVE GENE MARKERS 
To analyze key migratory and proliferative gene makers, quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) was performed.  In order to collect the 
mRNA, 750,000 tumor cells were seeded onto each substrate. Twenty-four hours post-
seeding, the media was removed and RLT Buffer (Qiagen, Venlo, Netherlands) was added to 
the cultures for 20 minutes to lyse cells.  The solution was then collected, processed, and 
purified using the RNeasy kit (Qiagen).  The mRNA concentration for each sample was 
measured at the 260/280 absorbance using NanoDrop 2000 spectrophotometer (Thermo 
Fisher Scientific).  The cDNA was made using the equivalent of 1 µg of RNA and iScript 
cDNA synthesis kit (Bio-Rad, Hercules, CA). Migratory markers, zinc finger protein SNAI1 
(SNAI1), Notch homolog 1 (NOTCH1), and reversion-inducing-cysteine-rich protein with 
kazal motifs (RECK), and proliferative markers, cyclin-dependent kinase 20 (CDK20), and 
cyclin D1 (CCND1), were probed using the iTaq SYBR Green Supermix (Bio-Rad).  For 
analysis of each gene, and the values were normalized to the housekeeping gene GAPDH. 
Primer sequences are listed in Table 1.   
Table 1: Forward and Reverse Primers 
Gene Forward Primer Reverse Primer 
GAPDH 5'-TGTAGTTGAGGTCAATGAAGGG-3' 5'-ACATCGCTCAGACACCATG-3' 
STAT3 5'-CAGTGACCAGGCAGAAGATG-3 5'-GCTCACTCACGATGCTTCTC-3' 
SNAI1 5'-GGTTCTTCTGCGCTACTGC-3' 5'-GCTGGAAGGTAAACTCTGGATT-3 
NOTCH1 5'-CAGGCAATCCGAGGACTATG-3' 5'-CAGGCGTGTTGTTCTCACAG-3 
RECK 5'-CAATAGCCAGTTCACAGCAG-3' 5'-CCAGATTATTGCCCAGAGACA-3' 
CDK20 5'-CAGTGTCTGCCTTCTATCCTG-3' 5'-TGTACCACATACTGATTGTCCTC-3’ 
CCND1 5'-GCCCTCGGTGTCCTACTTC-3' 5'-CTGTTCCTCGCAGACCTCC-3' 
 
4.8. FACS CELL CYCLE ANALYSIS 
In order to synchronize populations into the G0 phase, cells were serum started for 
24 hours in 1% FBS. Upon subculture, 500,000 cells were plated onto collagen coated 
substrates in normal growth media. After 3 days, cells were trypsinized, fixed in 70% 
ethanol overnight and incubated with Ribonuclease A (Life Technologies) and propidium 
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iodide (Life Technologies) for 30 minutes. DNA content from single cells were analyzed 
using a BD Accuri C6 flow cytometer, and completed in triplicate.  
4.9. STATISTICAL ANALYSIS 
All statistical analysis was performed by using GraphPad Prism (GraphPad Software, 
San Diego, CA). Data were reported as mean ± standard error of the mean (SEM), and either 
a t-test or a one-way ANOVA with Tukey’s post-hoc analysis was performed. Data were 
considered statistically significant with a p value < 0.05, unless stated otherwise stated.  
5 .   
 
3.   
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CHAPTER 5: RESULTS AND DISCUSSION 
 In this study, we investigated how the cytoskeletal mechanical properties of GBM 
tumor cells correlate to their invasive potential. Additionally, we analyzed whether the 
cytoskeletal mechanical properties altered based upon the alignment and nanotopography 
of the substrates.  Our data showed that the more invasive GBM tumor cells were more 
compliant and exerted less traction forces than the primary astrocytes that have less 
invasive potential. Furthermore, when seeded on an aligned nanotopographic substrate 
that mimicked the in vivo tumor microenvironment, cytoskeletal stiffness further 
decreased and an increased expression of migratory related genes were observed, 
suggesting that substrate nanotopography and alignment have an effect on the mechanisms 
involved in GBM invasion.  
5.1. SPECIFIC AIM 1 
5.1.1. GREATER CYTOSKELETAL STIFFNESS OBSERVED IN ASTROCYTES THAN IN GBM 
TUMOR CELLS 
As GBM is categorized as a Grade IV astrocytoma, atomic force microscopy (AFM) 
was used to determine if there were differences in cytoskeletal stiffness between GBM 
tumor cells and non-cancerous, healthy primary astrocytes. For the GBM cells, GBM cell 
lines (U87MG and A172), and primary GBM CICs were used. Primary GBM most commonly 
arises directly from astrocytes or glial precursor cells after they undergo genetic 
alterations (i.e. EGFR amplification/mutation, PTEN loss/mutation, etc.) [82], thus primary 
rat post-natal day 2 astrocytes were used as the non-cancerous, healthy cells. While human 
astrocytes would be the ideal model to use, they are more difficult to obtain compared to 
rat astrocytes. In addition, as with human astrocytes, as adults get older, the astrocytes are 
more susceptible to undergo genetic mutations, and are therefore not a true representation 
of a healthy astrocyte. With astrocytes obtained from a post-natal rat pup, the likelihood of 
these genetic aberrations is further reduced. Therefore, rodent astrocytes are commonly 
used as a model for similar measurements in humans [83]. In addition, although human 
astrocytes are larger than rat astrocytes, when comparing the actin organization, both 
types observe F-actin organized in stress fibers [83, 84].  
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Average stiffness measurements and representative images for each cell type are 
shown in Figure 8. Astrocytes were significantly (p<0.0001) stiffer than each tumor cell 
type, with an average stiffness of 4184 ± 102.3 Pa. There was no statistical difference 
between the two GBM cell lines, U87MG and A172 tumor cells, which had an average 
stiffness of 1315 ± 39.98 Pa and 1138 ± 68.58 Pa, respectively. Primary GBM CICs, BT145, 
were statistically (p<0.05) less stiff than the primary astrocytes and the GBM tumor cell 
lines, with an average stiffness of 653.3 ± 35.37 Pa (Figure 8A). Finally, cytoskeletal 
stiffness of differentiated BT145s (dBT145) was 1308 ± 90.02 Pa (Figure 8B). 
Morphologies of the cells were also noticeably different between the various cell types 
(Figure 8C). Astrocyte morphology was more spread on the TCPS compared to the spindled 
morphology exhibited in the tumor cells.  
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Figure 8: Cytoskeletal stiffness of cells decreases with increasing invasive potential. Atomic force microscopy was used to 
determine stiffness of primary astrocytes and GBM tumor cells when plated on collagen coated TCPS. A) Cytoskeletal stiffness of primary 
rat astrocytes, GBM cell lines, U87MG and A172, and primary GBM CICs, BT145. Analysis showed that GBM tumor cells were significantly 
softer than healthy astrocytes (p<0.0001). Further, highly invasive CICs were significantly less stiff than less invasive GBM cell lines 
(p<0.05). B) After differentiation of CICs with FBS, stiffness of cells significantly increased 2-fold (p<0.01). C) Representative brightfield 
images of astrocytes and tumor cells.  N=3, mean ± SEM.  
As a healthy cell undergoes oncogenic mutations, many cellular attributes are 
altered resulting in the abnormal growth and migratory behavior of cells [12]. Due to the 
role of the cytoskeleton on cell migration, previous studies identified biophysical attributes, 
specifically cytoskeletal stiffness, as a biomarker for invasive potential in a variety of 
cancers. Tumor studies using AFM to measure cytoskeletal stiffness have shown that more 
invasive breast, ovarian, and prostate cancer cells are less stiff than their less invasive or 
benign or healthy cell counterparts [16, 18, 24]. Significant 2-5 fold reductions in stiffness 
were observed between immortalized ovarian surface epithelial cells and different ovarian 
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cancer cell lines [18]. Similar results were observed in our experiments with the GBM 
tumor cells, as the highly invasive CICs were more compliant than the cancer cell lines 
U87MG and A172, which together, were significantly softer than non-cancerous astrocytes. 
During invasion, cancer cells need to deform their bodies in order to conform to the 
surrounding tissue in order to migrate. The reduced stiffness indicates a greater capability 
to deform within the aggressive tumor cells, which facilitates the migration and invasion 
through the surrounding ECM leading to secondary tumors [12].  
5.1.2. CELLULAR TRACTION FORCES GREATER IN ASTROCYTES THAN GBM TUMOR CELLS 
Total cell traction force of the primary astrocytes, U87MG, A172, and BT145 were 
measured using traction force microscopy (TFM) (Figure 9).  Cells were seeded on 
polyacrylamide gels overnight before being measured. For the primary astrocytes, a stiffer 
gel was used to measure the cell traction forces as the softer gels used for the tumor cells 
were too compliant and were pulled by the extremely contractile astrocytes, thus causing 
the beads to be in a different focal plane than the rest of the gel.  This caused inaccurate 
measurements to be taken (data not shown). Therefore, a stiffer gel using 8% acrylamide 
and 0.1%-bis-acrylamide was used for the astrocytes. As the BT145s did not adhere well or 
generate traction on the aforementioned gel, a 5% acrylamide and 0.08%-bis-acrylamide 
gel was used for BT145. As gel stiffness influences traction force generated, U87MG and 
A172 cells were plated on both the 8% and 5% gel, and compared with the traction forces 
from the astrocytes and BT145s, respectively. 
Figure 9A illustrates that non-cancerous astrocytes exerted significantly more cell 
traction force on the gel compared to the malignant GBM tumor cells. The average cell 
traction forces exerted by the astrocytes was 1240 ± 87.1 nN compared to the 129 ± 30.4 
nN exerted by the malignant GBM tumor cells (p<0.0001).  When comparing the traction 
forces of the cell lines and primary CICs, the A172 tumor cells exerted significantly greater 
force on the gel compared to BT145 cells, with an average cell traction force of 35.0 ± 9.41 
nN and 5.60 ± 2.93 nN, respectively (p<0.05).  However, a statistical difference was not 
observed between the U87MG tumor cells (14.6 ± 5.59 nN) and the A172s or BT145 tumor 
cells. Figure 9B displays representative stress maps of the cells. For the non-cancerous 
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astrocytes, the maximum traction stresses reach as high as 775 Pa; however, the maximum 
traction stresses of malignant tumor cells are an order of magnitude smaller.  
 
Figure 9: Cell traction forces decrease with increasing cell invasive potential. A) Top panel: TFM analysis demonstrated that 
traction forces between healthy astrocytes and GBM tumor cells significantly decrease (p<0.0001), nearly 98%. Middle panel: When GBM 
tumor cells are separated based on cell type, there was a significantly difference (p<0.05) in force generated between tumor cell line 
A172 and CICs, as CICs generated 84% less force than A172 cells. No differences were observed between U87MG tumor cells and other 
cells. Bottom panel: Upon differentiation of CICs, traction force significantly increases (p<0.01) when compared to their non-
differentiated counterparts. B) Representative brightfield and stress maps of astrocytes and tumor cells. Stronger stresses are observed 
throughout the entire cell body of astrocytes. Weaker stresses, however, are observed on tumor cells. Furthermore, these stresses are 
primarily polarized. N=3, mean ± SEM. 
Cellular traction forces, both total force and traction stresses, have also been 
investigated in other cancers to demonstrate how differing traction stresses can be 
correlative of invasive potential in cancer cells; however, conflicting results have been 
reported. Similar to what was observed in this study, an inverse relationship between 
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traction stress and cell metastatic potential in breast cancer cells and transformed 
fibroblasts was observed [70, 85]. However, other studies investigating breast, prostate, 
and lung cancer cells, showed that these cell types exerted significantly more total cell 
traction force than their non-metastatic counterparts [69]. One potential reason for the 
differing results is that traction forces are correlative with cell surface area and shape and 
the astrocytes observed in this study had a larger area than the GBM tumor cells. As a cell 
extends, traction forces play a key role in stretching the cell membrane and aid in 
maintaining contact with the substratum [86]. With high cell tension and a large area, the 
astrocytes cells likely form strong cell-matrix adhesions, thereby inhibiting migration.  
5.1.3. ACTIN AND FOCAL ADHESION ANALYSIS OF ASTROCYTES AND GBM TUMOR CELLS 
CONFIRM THAT INVASIVE POTENTIAL IS ASSOCIATED WITH REDUCED FOCAL ADHESION 
PRESENCE 
To determine if there were differences in cytoskeletal organization between 
astrocytes and malignant tumor cells, the cells were stained for vinculin (red), a focal 
adhesion protein, as well as F-actin (green) (Figure 10). The fluorescent images of the 
vinculin and F-actin co-stain can be seen in Figure 10A. Astrocytes exhibited aligned, 
densely-packed stress fiber networks distributed throughout the cell body, while actin 
distribution in GBM tumor cells appeared less dense. As marked differences were noted in 
focal adhesion formation, the percentage of positive vinculin area within a cell was 
quantified for the astrocytes and the GBM cell lines, U87MG, and A172. As astrocytes 
displayed a larger spreading area than the tumor cells, the ratio of vinculin area to cell area 
provides a reliable normalized measurement.  As seen in Figure 10B, astrocytes exhibited 
significantly larger focal adhesion areas (22.51 ± 2.52%) than the U87MG (4.362 ± 1.12%) 
and A172 (12.50 ± 1.66%) tumor cells (p<0.05). A statistical difference was not observed in 
the percentage of positive vinculin area between the two GBM cell lines, U87MG and A172 
tumor cells. This reduction in focal adhesion area also provides reason as to why the GBM 
tumor cells had weaker cell traction forces. The primary BT145 CICs were stained for 
vinculin and actin; however, observable amount of vinculin was not positively stained, 
which may be due to the CICs being a non-adherent tumor sub-population and vinculin not 
being localized to the focal adhesions. 
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Figure 10: Cytoskeletal organization of astrocytes and tumor cells by staining for vinculin, a focal adhesion protein, and F-actin. 
A) Representative images of astrocytes and tumor cells of vinculin (red), F-actin (green), and counterstained with Hoechst (blue). 
Densely organized actin networks were observed in astrocyte cultures; however disorganized actin filaments were observed in U87MG 
and A172 tumor cell cultures. Further, vinculin was largely was localized throughout the entire cell body of astrocytes, however 
primarily localized to the periphery of tumor cells. B) Quantification of focal adhesions demonstrated that tumor cells resulted in 
significant reduction (p<0.05) in vinculin area/cell area compared to healthy astrocytes. N=3, mean ± SEM. 
The differing biomechanical properties between the cancer and non-cancer cells are 
largely due to the changes in the cytoskeleton organization. Similar to what was observed 
in this study, it has been shown that non-malignant breast and ovarian cells formed a dense 
network of parallel actin filaments distributed throughout the cell body, however, their 
cancerous counterparts formed fewer filaments, most of which were shorter and largely 
disorganized, leading to the reduction in cytoskeletal stiffness [16, 18]. Focal adhesion 
complexes play a role in cell migration, as well as adhesion to the substratum. When focal 
adhesions attach and pull the surrounding ECM along the leading edge, traction forces are 
generated within the cell, moving the cell forward. In conjunction with focal adhesion 
formation, there must be a turnover of focal adhesion attachment at the trailing edge to 
allow for continuous directional cell migration [9].  Due to its role in migration, 
overexpression of vinculin has been shown to reduce cancer cell migration and invasion. 
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Conversely, a lack of vinculin expression has been associated with the development of 
many cancers, and potentially plays a role in epithelial-mesenchymal transition (EMT), 
thus suggesting a potential reason for the reduction of vinculin in the GBM cells [87]. 
5.1.4. ANALYSIS OF BIOMECHANICAL PROPERTIES CORRELATE CIC DIFFERENTIATION WITH 
DECREASED INVASIVE CAPABILITIES 
CICs, which are highly migratory and mainly responsible for tumor recurrence, are a 
key target for cancer therapies. As these cells are resistant to traditional chemotherapeutic 
strategies, differentiation therapy is being developed as an approach to treat GBM tumors 
to inhibit their stem-like phenotype thereby reducing tumorigenicity. By treating stem-like 
glioma cells with all-trans retinoic acid-containing medium to induce differentiation, 
Campos et al. showed a decrease in cellular invasion [88]. While the majority of other 
studies focus on the biochemical mechanism of CIC differentiation, we investigated the 
effect of differentiation on the biophysical properties of these cells.  
To determine if the difference in biophysical properties between the GBM cells lines 
and the GBM CICs was due to differentiation, the BT145 CICs were differentiated using 
media without EGF or FGF, but containing 10% FBS for 3 weeks. Following differentiation, 
the cytoskeletal stiffness, traction force, and percent of positive vinculin area were 
measured.  The cytoskeletal stiffness of the differentiated BT145 (dBT145) tumor cells 
significantly increased to 1310 ± 90.0 Pa (p<0.01), similar to that of the U87MG and A172 
tumor cell lines (Figure 8B). In addition, the cell traction forces of the dBT145s (39.03 ± 
4.384 nN) were measured and the traction forces significantly increased (p<0.01) 
compared to the primary BT145 tumor cells (Figure 9). Finally, positive vinculin staining 
was quantified, and contrary to their non-differentiated counterparts, the dBT145 tumor 
cells adhered well onto the surface with observed stress fiber formation and had a similar 
percentage of positive vinculin area (7.93 ± 0.92%) as the U87MG and A172 tumor cells 
(Figure 10).  
Moreover, cell morphologies between dBT145s and their non-differentiated 
counterparts were observably distinct. After differentiation, cytoskeletal stiffness, cell 
traction force, and percent of positive vinculin area significantly increased compared to 
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their undifferentiated CIC counterparts. In addition, these properties were similar to that of 
the less invasive cancer cell lines U87MG and A172, supporting that differentiation leads to 
a less invasive phenotype.  Therefore, this supports previous reports that state CICs have a 
more invasive potential than differentiated tumor cells [88-90]. 
5.2. SPECIFIC AIM 2 
5.2.1. CYTOSKELETAL STIFFNESS ANALYSIS OF CELLS ON ALIGNED NANOTOPOGRAPHY 
CORROBORATES THAT STIFFNESS IS CORRELATIVE OF INVASIVE POTENTIAL 
The measurement of cytoskeletal stiffness on a rigid 2D substrate provides 
important baseline characteristics of the cells; however it is important to measure these 
values on a scaffold that mimics the in vivo tumor microenvironment to obtain more 
biologically relevant results. Therefore, we used polycaprolactone (PCL) substrates 
(smooth film, randomly aligned nanofibers, and aligned nanofiber films) to investigate 
whether cell biomechanical properties would change. The nanofibers mimic the 
nanotopographical cues provided by the white matter tracts and blood vessels in the in vivo 
tumor microenvironment. Electrospun nanofibers have been previously used as a model 
for glioblastoma and breast cancer migration [21, 22, 76, 77].  
As GBM tumor cells migrate along white matter tracts and blood vessels, we used 
aligned PCL nanofibers to mimic these biological substrates, as well as randomly aligned 
nanofibers, and smooth film to observe if there was a difference in the cell behavior. By 
using a rotating mandrel, aligned nanofibers with an average diameter of 668 ± 98.6 nm 
were fabricated, within the range of diameters of white matter tracts observed in the 
human brain. While the diameters of these topographic substrates range from person to 
person (from 0.3 µm to 10 µm [91]), on average, median and average white matter tract 
diameters have been shown to be below 1 µm [92]. Randomly aligned nanofibers had an 
average diameter of 621 ± 173 nm. Degrees of alignment for aligned and randomly aligned 
nanofibers were 3.1 ± 2.3 degrees and 46.8 ± 54.8 degrees, with the positive y-axis being 0 
degrees. SEM images of the different substrates can be seen in Figure 11A.  The difference 
in alignment can be observed between the aligned and the randomly aligned nanofibers 
films. By using aligned nanofibers, randomly aligned nanofibers and a smooth, non-
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topographic film, we were able to investigate how nanotopography and fiber orientation 
affected cell behavior. 
 
Figure 11: Aligned nanotopography resulted in decreased cytoskeletal stiffness. A) Electrospinning was used to fabricate randomly 
aligned and aligned nanofibers of 621 ± 173 nm and 668 ± 98.6 nm, respectively. Lack of surface nanotopography is observed in smooth 
film. B) AFM was used to determine cytoskeletal stiffness of tumor cells when cultured on differing nanotopographic substrates. When 
cultured on aligned nanofibers, cytoskeletal stiffness significantly decreased (p<0.05) compared to each other substrate for each cell type. 
C) Representative fluorescent images of A172-GFP-actin tumor cells on different substrates. N=3, mean ± SEM.   
In order to determine the effect of nanotopography on cytoskeletal stiffness, AFM 
was used to measure the cytoskeletal stiffness of U87MG, A172, and BT145 tumor cells 
seeded on collagen coated TCPS, smooth film, randomly aligned nanofibers, and aligned 
nanofibers (Figure 11B). For both cell lines and CICs, the cytoskeletal stiffness was 
significantly smaller on the aligned nanofibers (p<0.05) compared to both randomly 
aligned nanofibers and smooth film with stiffness measurements of 995 ± 74.2 Pa, 984 ± 
107 Pa, and 661 ± 18.5 Pa, for the U87MG cells on the smooth film, randomly aligned 
nanofibers, and aligned nanofibers, respectively. Stiffness for U87MG tumor cells cultured 
on the aligned nanofibers decreased 2-fold compared to TCPS and about 1.5-fold compared 
to the other substrates. Similar trends in stiffness were also observed for A172 and BT145 
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tumor cells. Representative fluorescent images of cells on each substrate can be seen in 
Figure 11C. 
It has been shown previously that cells cultured on aligned nanofibers migrate 
further and up to five times faster than on randomly aligned nanofibers or substrates 
without nanotopography, similar to tumor cell migration speeds in vivo [21, 76, 78]. 
Together, with the earlier data that showed that cytoskeletal stiffness is a biomarker for 
GBM invasive potential, we see that the more invasive a cell is, the more compliant it is. The 
actin cytoskeleton is undergoing rapid depolymerization and polymerization during 
migration, which likely leads to the reduced stiffness [93]. In addition, Rosa-Cusachs et al. 
investigated how the elongated cell shape affects the actin cytoskeleton and reduced 
cytoskeletal stiffness in endothelial cells [94].  They suggest that the spatial organization of 
the actin cytoskeleton of elongated cells is part of the reason of a reduced cytoskeletal 
stiffness, due to the reduction of crosslinking in parallel actin networks compared to a 
densely crosslinked network of spread cells [94]. This data highlights that an aligned 
nanotopography has the ability to alter cytoskeletal stiffness, thereby promoting a more 
migratory cell state.  
Previously MacKay et al. investigated the effects of genetically manipulating glioma 
cells by delivering constitutively active RhoA to determine the effect on the cell’s 
mechanical properties.  It was found that increasing constitutively active RhoA expression 
led to increased traction forces and decreased cell migration speeds. This reduction in 
migration was likely due to the cells adhering too strongly to the substratum [95].  
However, investigating the mechanical properties by mimicking the nanotopography of the 
blood vessels and white matter tracts has not been investigated. 
5.2.2. NANOTOPOGRAPHY AND ALIGNMENT CORRELATES WITH ENHANCED MIGRATORY AND 
REDUCED PROLIFERATIVE PHENOTYPE IN TUMOR CELLS 
With the effect of nanotopography on the biomechanical attributes of cells 
investigated, further analysis on gene expression along the migratory signaling pathways 
was completed using qRT-PCR. Gene expression analysis was completed for pro-migratory 
gene markers zinc finger protein SNAI1 (SNAI1) and Notch homolog 1 (NOTCH1), anti-
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migratory gene marker reversion-inducing-cysteine-rich protein with kazzal motifs (RECK), 
and pro-proliferative gene markers cyclin-dependent kinase 20 (CDK20) and cyclin D1 
(CCND1).  U87MG and A172 tumor cells exhibited greater than ± 2 fold changes for all of 
the investigated genes when seeded on the aligned nanofibers compared to TCPS (Figure 
12). The fold increase on the aligned nanofibers compared to TCPS for pro-migratory 
SNAI1 and NOTCH1 markers was 10.12 and 3.39 for U87MG tumor cells, and 16.75 and 
3.09 for A172 tumor cells, respectively. Anti-migratory RECK was downregulated 3.10 and 
3.83 fold in the U87MG and A172 tumor cells, respectively.  
Pro-proliferative gene markers CDK20 and CCND1 were also downregulated 2.72 
and 2.02 fold compared to TCPS for U87MG cells. Similar decreased gene expression was 
observed in A172 tumor cells, with 2.99 and 2.54 fold respective downregulation. 
Furthermore, there were statistical differences between the aligned nanofiber films and the 
smooth film substrate for all of the analyzed genes. When comparing the gene expression of 
the A172 tumor cells on aligned nanofibers and randomly aligned nanofibers for NOTCH1, 
a greater than 2-fold difference was observed. However, for the U87MG cells on the aligned 
nanofibers and randomly aligned nanofibers, a greater than 2-fold expression difference 
was observed for the expression of SNAI1. 
 
Figure 12: Aligned nanotopography resulted in the most significant increase in pro-migratory and decrease in pro-proliferative 
gene markers. Quantitative real time PCR for gene expression in U87MG (A) and A172 (B) cells when plated on TCPS, smooth film, 
randomly aligned nanofibers, and aligned nanofibers for 24 hours. Results are shown with fold expression relative to the TCPS condition. 
Aligned nanotopography resulted in the significant upregulation of pro-migratory marker SNAI1 and NOTCH1, downregulation of anti-
migratory marker RECK, and decreased pro-proliferative markers CDK20 and CCND1 (p<0.05). N=3, mean ± SEM.  
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Previous studies have shown culturing of GBM tumor cells on aligned chitosan-PCL 
fibers of 200 and 400 nm resulted in the significant upregulation of several migratory and 
EMT gene markers [76].  Our data demonstrated a significant increase of SNAI1 and 
NOTCH1 expression on the aligned nanofibers. Notch signaling has been shown to promote 
EMT through regulation of SNAI1 [42, 43].  Zhang et al. showed that elevation of NOTCH1 
signaling in GBM cells and in tumor biopsies led to increased tumor invasion and EMT 
markers expression [41]. Downregulation of metastasis suppressor RECK, which was 
observed on the aligned nanofibers, is essential for the invasiveness in GBM cells, as 
overexpression of RECK in T98G glioblastoma tumor cells altered the cytoskeleton to 
produce fewer lamellipodia and greater stress fibers, indicating decreased mobility [48].  
In addition, we also investigated the effect of substrate nanotopography on genes 
responsible for proliferation. GBM tumors have exhibited a “go-or-grow” phenomenon in 
which there is a dichotomy between the migratory (go) and proliferative (grow) behavior 
of the tumor cells. Previous studies have shown that invading cells at the leading edge of 
the tumor have low proliferative index by inhibiting entry into the cell cycle, while cells 
located in the tumor core are highly proliferative, in vitro and in vivo [53, 55-57]. Using an 
implantable nanofiber film to direct tumor cell migration, Jain et al. showed that cells 
migrating away from the tumor core were in a less proliferative state on the aligned 
nanofibers compared to a smooth film control, as suggested with the reduced Ki67 staining. 
F-actin staining analysis showed that cells grown on the aligned nanofiber film exhibited 
uniform F-actin filaments compared to more punctate F-actin staining of cells on a smooth 
film, suggesting a less migratory, suspended state on the smooth film [21]. Gene expression 
of  CDK20 and CCND1, both of which play a role in the transition from the G1/S phase in the 
cell cycle, were significantly downregulated on the aligned nanofibers, with a greater than 
2-fold decrease compared to the TCPS control, further purporting that substrate 
nanotopography induces a propensity for a migratory GBM tumor cell state [50, 96]. 
5.2.3. ALIGNED NANOTOPOGRAPHY PROMOTES TUMOR CELLS TO BE IN G1 PHASE OF CELL 
CYCLE 
To further investigate how substrate nanotopography affects cell state, cell cycle 
analysis by DNA content was completed using flow cytometry. As shown in Figure 13 cells 
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on the aligned fibers had a significantly greater population of cells in the G1 phase than 
when grown on non-topographic TCPS (p<0.05, 71.3 ± 0.9% versus 65.4 ± 1.1%, 
respectively); however, no statistical differences were observed between any other groups, 
with 66.8 ± 0.3% and 67.1 ± 1.4% cells being in the G1 phase on the smooth film and 
randomly oriented nanofiber substrates, respectively. In addition, there was a significant 
reduction (p<0.01) in population of cells in the S phase when cultured on aligned 
nanofibers (8.9 ± 0.8%) compared to when cultured on smooth film (13.8 ± 0.3%). No 
significant differences in the S phase were observed between these groups and cells grown 
on TCPS (12.0 ± 0.8%) and randomly aligned nanofibers (12.1 ± 1.1%). Interestingly, no 
significant differences in percent population in the G2/M phase were observed between 
any group, with 22.7 ± 1.2%, 19.4 ± 0.3%, 20.8 ± 0.4%, and 19.8 ± 1.3% in the G2/M phase 
on TCPS, smooth film, randomly aligned nanofibers, and aligned nanofibers, respectively.  
 
Figure 13: Cell cycle analysis by DNA content for tumor cells on TCPS, smooth film, randomly aligned, and aligned nanofibers 
showed aligned nanotopography promotes enhanced population in the G1 phase of the cell cycle. Analysis of FACS histograms of 
population of cells in the (a) G1 phase, (b) S phase, and (c) G2/M phase of the cell cycle. Analysis shows that there is a significant increase 
in cells in the G1 phase of the cell cycle on the aligned nanofibers compared to TCPS. N=3, mean ± SEM.  
These data support the earlier gene expression analysis that the cells on the aligned 
nanofibers are less in a proliferative phase due to the increase of population in the G1 
phase of the cell cycle. In addition, similar results have been previously reported in gastric 
cancer cells cultured in Gelfoam® histoculture to mimic metastasis. It was found invading 
cancer cells were predominantly in the G0/G1 phase of the cell cycle instead of S/G2/M 
phases. In addition, they found cells in the  G0/G1 migrated faster and further than cells in 
the proliferative phases, and upon entering the S-phase, migration ceased until mitosis 
finished [97]. One benefit of this study compared to our study is cell phase at the tumor 
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periphery and core were quantified separately, thus minimizing confounding effects of the 
highly proliferative tumor core.  
5.2.4. MORPHOMETRIC ANALYSIS OF FOCAL ADHESIONS CORRELATE LARGER, ELONGATED 
ADHESIONS WITH A MIGRATORY STATE 
The cytoskeletal organization of cells on glass, randomly aligned nanofibers, and 
aligned nanofibers was analyzed to further describe the effect of nanotopography on the 
cytoskeleton. As seen in Figure 14, cells on the aligned nanofibers formed parallel actin 
filaments along the direction of the fibers. In addition, clusters of focal adhesions can be 
observed along the poles of these cells. Cells on randomly aligned fibers observed a 
randomly spread morphology, forming extensions in different directions along the fibers. 
Individual vinculin adhesions were characterized by area, length, and shape factor (Figure 
14B). Focal adhesions on the aligned nanofibers were significantly larger in area and length 
than the adhesions on glass or randomly aligned nanofibers. Focal adhesion areas on 
aligned nanofibers, randomly aligned nanofibers, and glass were 5.74 ± 0.441 µm2, 3.91 ± 
0.268 µm2, and 2.96 ± 0.209 µm2 respectively. In addition, adhesions also had a significantly 
smaller shape factor (4π(area)/(perimeter)2) on the aligned nanofibers (0.63 ± 0.020), 
indicating that the adhesions exhibited a more elongated, elliptical shape than those 
cultured on glass (0.76 ± 0.17) and randomly aligned nanofibers (0.81 ± 0.012).  
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Figure 14: Aligned nanotopography promotes larger and more elongated focal adhesions. A) Representative images of U87MG 
tumor cells of vinculin (red), F-actin (green), and counterstained with Hoechst (blue) on aligned and randomly aligned nanofibers. White 
box highlights a magnified area in the inset for the fluorescent images showing vinculin staining. Aligned nanofibers promoted a spindled 
morphology, while randomly aligned nanofibers exhibited cells with multiple processes along the fiber directions. B) Quantification and 
analysis of vinculin adhesions showed that cells on aligned nanofibers had adhesions that were significantly larger in area, longer, and 
more elliptical (p<0.001) then when on randomly aligned fibers or glass. N=21, mean ± SEM  
Substrate and ECM nanotopography have an effect on stress fiber and focal adhesion 
formation. Human mesenchymal stem cells cultured on 500 nm gratings of TCPS exhibited 
increased vinculin protein expression compared to unpatterned controls. In addition, the 
cells on the nanotopographic substrates exhibited a reduction in cytoskeletal stiffness and 
an elongated morphology with an aligned actin cytoskeleton and a dense focal adhesion 
population around the poles of the cells, compared to adhesions localized to both the 
central and peripheral region on cells on unpatterned substrates [10]. Similar results were 
found across a variety of cell types including epithelial, kidney, and fibroblast cells [36-38].  
In addition, Kim et al. investigated the effects of individual focal adhesion size on cell 
motility in mouse embryonic fibroblasts. While a moderately correlative inverse linear 
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relationship was found between shape factor and cell migration speed, they found that 
focal adhesion size was highly predictive of cell speed [98]. Similar results were also 
observed with C2C12 mouse myoblast cells cultured on aligned suspended nanofibers. 
These cells exhibited higher migration speeds, with focal adhesion clusters approximately 
4x times longer than when grown on a non-topographic substrate. An increased presence 
of longer filopodia along the lamellipodial leading edge have been observed on cells on an 
aligned topography, and likely aid in enhancing the migration speed [99]. Together, this 
suggests the aligned nanotopography provides the guidance cues necessary to reorganize 
the cytoskeleton to promote a propensity for a migratory state.  
6 .    
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CHAPTER 6: FUTURE WORK AND CONCLUSIONS 
6.1. FUTURE WORK 
Studying the biomechanical properties as a biomarker for invasive potential has 
been studied previously in other cancers however has yet to be reported in GBM. While this 
study used astrocytes as a healthy control, GBM is also believed to possibly arise from glial 
precursor cells and neural stem cells. In addition, while the majority of GBM arises from the 
de novo pathway (through astrocytes, glial precursor cells, or neural stem cells), GBM can 
also arise through the progression of lower grade astrocytomas. This study just focused on 
GBM cell lines and highly invasive CICs, thus there is a large gap between healthy cells and 
Grade IV astrocytoma cells. Therefore, using additional controls of neural stem cells and 
low grade or benign brain tumors, such as pilocytic astrocytomas, a more comprehensive 
analysis of using cell stiffness or traction forces as a biomarker for invasive potential could 
be completed. In addition, it may provide answers for the conflicting traction force results 
observed in this study compared to other cancers.  
Further, while this study set the groundwork for the in vitro model and identified 
biomechanical differences between the cells on the aligned nanofibers, moving forward, we 
would like to elucidate the mechanism that leads to the enhanced migratory cell state. This 
model can be used to monitor what is happening in vivo at a faster rate with more 
biologically relevant results than on previously used models. In order to investigate 
potential mechanisms, cells can be transduced to identify proteins of interest, and then 
plated onto these nanofiber films and placed into a live imaging chamber. This will allow 
for quantification of protein trafficking within the cell that plays a role in migration. In 
addition, by using a live imaging chamber, vinculin, or other focal adhesion proteins, and F-
actin can be fluorescently tagged to exhibit cytoskeletal dynamics during migration on 
these substrates. By identifying the mechanism involved in the altering gene and protein 
expression, more effective therapies can be developed to inhibit the infiltrative nature of 
these cells.  
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Additionally, one aspect that was not investigated in this study was the nanofiber 
material, as here, only collagen coated PCL nanofibers were used. As PCL is a synthetic 
polymer and is not comparable to the mechanical or chemical properties of the white 
matter tracts or blood vessels, electrospinning hyaluronic acid or collagen nanofibers could 
be used to create a model more mimetic of the migratory paths. It has been previously 
shown that spinning a PCL core with an HA or collagen shell affected the initial attachment, 
cell stretching, and migration rate of GBM tumor cells, thus surface chemistry is just as 
important as the physical nanotopography of the substrate [77].  
Unfortunately, due to technical limitations, the gene expression analysis was not 
completed on the primary CICs. While attempts were made to collect RNA from these 
samples, they were unsuccessful due to low yields and poor 260/280 ratios. Therefore, 
more optimization would need to be completed in order to obtain gene expression on the 
CICs when plated on the nanofiber substrates. Once optimized, it would of interest to see if 
conventional CIC markers (CD133, nestin, etc.) are regulated by nanotopographical 
patterning as well. In addition, protein expression analysis via western blotting of 
migratory and proliferative markers could also be completed to further support the claims 
suggested in this study.   
6.2. BROADER APPLICATIONS AND IMPLICATIONS 
While the work presented here was focused on GBM, the nanofiber model has 
broader applications and can be used as a research tool for cancer cell migration [3]. 
Nanofibers have already been used to study breast cancer cell migration, however it can 
also be applied to other highly invasive cancers, such as pancreatic cancer, to help elucidate 
the migratory mechanism. Identifying the migratory mechanism responsible for the 
enhanced invasive nature of these diseases will help researchers identify gene or protein 
targets for therapies to minimize invasion.  
Further, due to the heterogeneity of GBM, not all treatments will work across all 
patients. With this in vitro model, researchers can quickly monitor what is happening in 
vivo on a microscopic scale. The aligned nanofibers can be used as an in vitro diagnostic 
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tool for tumor biopsies to complete genotype/phenotype analysis, and provide drug 
screening for development of personalized treatment therapies. 
6.3. CONCLUSION 
 This study investigated the biomechanical properties of highly aggressive and 
migratory GBM tumor cells. We demonstrate that the cytoskeletal stiffness, traction forces, 
and focal adhesion formation is significantly reduced in the highly invasive tumor cells 
compared to healthy astrocytes. In addition, by using an aligned nanofiber film that mimics 
the white matter tracts and blood vessels highways for cell migration, we observed a 
reduction in cytoskeletal stiffness likely due to the reduction in crosslinking in an aligned 
actin cytoskeleton. Together, with the upregulation of migratory related genes on the 
aligned nanofibers, aligned actin cytoskeleton, and increased presence of larger, elongated 
adhesions, these data suggest the aligned nanotopography promotes the biophysical 
changes in the cells leading to an enhanced migratory state, as shown in Figure 15 .  Testing 
the biomechanical properties of GBM is an effective diagnostic methodology to determine 
the aggressiveness of GBM tumor.  This in vitro model can further be applied to elucidate 
how the nanotopography of the substrates transduces into altered gene and protein 
expression to induce tumor cell invasion and migration, thus providing a mechanism to 
inhibit the process to form secondary tumor sites.  
 
Figure 15: Graphical conclusion of enhanced migratory state of GBM tumor cells the aligned nanofibers 
  
1) Aligned nanotopography promotes
aligned actin cytoskeleton
2) Reduced actin crosslinking between
filaments in aligned cytoskeleton
3) Reduced crosslinking leads to
reduction in cell stiffness
4) Lack of crosslinking aids in
enhanced depolymerization and
repolymerzation of actin, leading to
enhanced migratory state
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